LCAT and Alzheimer disease: Post hoc comparisons indicated the HDL LCAT activity was significantly higher in the control group vs. MCI (1.05 ± 0.09 vs. 1.01 ± 0.07, p = 0.030) but not significantly higher than the AD group (1.03 ± 0.07, p = 0.118, Figure 1B).